BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 15318714)

  • 1. [Optimal conditions for producing immunomodulating effect of epithalamine as component of neoadjuvant chemotherapy using autoplasma and autoblood in patients with locally advanced breast cancer].
    Zlamnik EIu; Vladimirova LIu; Zakora GI
    Vopr Onkol; 2004; 50(3):357-60. PubMed ID: 15318714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of new chemotherapeutic methods on the biologic tissue environment and on the immune status of patients with breast cancer].
    Sidorenko IuS; Zlatnik EIu; Vladimirova LIu; Zakora GI
    Vopr Onkol; 2002; 48(2):202-5. PubMed ID: 12227069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant chemotherapy for locally advanced breast cancer: a review of the literature and future directions.
    Mathew J; Asgeirsson KS; Cheung KL; Chan S; Dahda A; Robertson JF
    Eur J Surg Oncol; 2009 Feb; 35(2):113-22. PubMed ID: 18502088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pathological manifestation and feasibility of conservative breast surgery after effective neoadjuvant chemotherapy for breast cancer].
    Liu CP; Shi L; Li Z
    Zhonghua Wai Ke Za Zhi; 2008 Sep; 46(18):1394-6. PubMed ID: 19094510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant chemotherapy with vinorelbine-containing regimens in elderly patients with locally advanced breast cancer.
    Ma CD; Chen CM; Chen XS; Liu GY; Di GH; Wu J; Lu JS; Yang WT; Chen JY; Shao ZM; Shen ZZ; Shen KW
    Anticancer Res; 2008; 28(5B):3093-7. PubMed ID: 19031963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrence rates after DCE-MRI image guided planning for breast-conserving surgery following neoadjuvant chemotherapy for locally advanced breast cancer patients.
    Garimella V; Qutob O; Fox JN; Long ED; Chaturvedi A; Turnbull LW; Drew PJ
    Eur J Surg Oncol; 2007 Mar; 33(2):157-61. PubMed ID: 17085007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Improvement of the indicators of cellular immunity under the effect of polypeptide epiphyseal extract (epithalamine)].
    Dil'man VM
    Vopr Onkol; 1977; 23(6):7-9. PubMed ID: 303411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoadjuvant chemotherapy followed by concurrent hyperfractionated radiation therapy and sensitizing chemotherapy for locally advanced (T3-T4) oropharyngeal squamous cell carcinoma.
    Finnegan V; Parsons JT; Greene BD; Sharma V
    Head Neck; 2009 Feb; 31(2):167-74. PubMed ID: 18853443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fifteen-year results of a randomized prospective trial of hyperfractionated chest wall irradiation versus once-daily chest wall irradiation after chemotherapy and mastectomy for patients with locally advanced noninflammatory breast cancer.
    Buchholz TA; Strom EA; Oswald MJ; Perkins GH; Oh J; Domain D; Yu TK; Woodward WA; Tereffe W; Singletary SE; Thomas E; Buzdar AU; Hortobagyi GN; McNeese MD
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1155-60. PubMed ID: 16750325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoadjuvant chemotherapy in stage III breast cancer.
    Alassas M; Chu Q; Burton G; Ampil F; Mizell J; Li BD
    Am Surg; 2005 Jun; 71(6):487-92. PubMed ID: 16044927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of response to repeat utilization of anthracycline in recurrent breast cancer patients previously administered anthracycline-containing chemotherapeutic regimens as neoadjuvant or adjuvant chemotherapy.
    Yonemori K; Katsumata N; Kaneko M; Uno H; Matsumoto K; Kouno T; Shimizu C; Ando M; Takeuchi M; Fujiwara Y
    Breast Cancer Res Treat; 2007 Jul; 103(3):313-8. PubMed ID: 17063267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of dynamic contrast enhanced MRI in monitoring early response of locally advanced breast cancer to neoadjuvant chemotherapy.
    Pickles MD; Lowry M; Manton DJ; Gibbs P; Turnbull LW
    Breast Cancer Res Treat; 2005 May; 91(1):1-10. PubMed ID: 15868426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neoadjuvant chemotherapy with docetaxel plus epirubicin for locally advanced breast cancer: a multi-center phase II study].
    Shen ZZ; Liu GY; Su FX; He PQ; Yang MT; Shi JY; Sheng Y; Zou Q; Li YF
    Zhonghua Zhong Liu Za Zhi; 2005 Feb; 27(2):126-8. PubMed ID: 15946557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients.
    Capirci C; Valentini V; Cionini L; De Paoli A; Rodel C; Glynne-Jones R; Coco C; Romano M; Mantello G; Palazzi S; Mattia FO; Friso ML; Genovesi D; Vidali C; Gambacorta MA; Buffoli A; Lupattelli M; Favretto MS; La Torre G
    Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):99-107. PubMed ID: 18407433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant chemotherapy for locally advanced breast cancer.
    Specht J; Gralow JR
    Semin Radiat Oncol; 2009 Oct; 19(4):222-8. PubMed ID: 19732686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of neoadjuvant chemotherapy on estrogen and progesterone receptors and HER-2 in breast cancer].
    Zhao J; Wu YL; Wang YD; Zhao GR; Wang J
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Dec; 24(12):1437-9. PubMed ID: 15604081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy.
    Keam B; Im SA; Kim HJ; Oh DY; Kim JH; Lee SH; Chie EK; Han W; Kim DW; Cho N; Moon WK; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
    Breast Cancer Res Treat; 2009 Jul; 116(1):153-60. PubMed ID: 18787948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative chemotherapy treatment of breast cancer--a review.
    Buzdar AU
    Cancer; 2007 Dec; 110(11):2394-407. PubMed ID: 17941030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of locoregional recurrence in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy, mastectomy, and radiotherapy.
    Huang EH; Tucker SL; Strom EA; McNeese MD; Kuerer HM; Hortobagyi GN; Buzdar AU; Valero V; Perkins GH; Schechter NR; Hunt KK; Sahin AA; Buchholz TA
    Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):351-7. PubMed ID: 15890574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose chemotherapy and autologous peripheral blood stem cell transplantation for primary breast cancer refractory to neoadjuvant chemotherapy.
    Ueno NT; Konoplev S; Buchholz TA; Smith T; Rondón G; Anderlini P; Giralt SA; Gajewski JL; Donato ML; Cristofanilli M; Champlin RE
    Bone Marrow Transplant; 2006 May; 37(10):929-35. PubMed ID: 16565737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.